SRS Capital Advisors Inc. Raises Holdings in Amgen, Inc.
SRS Capital Advisors Inc. raised its stake in Amgen, Inc. by 21.3% in the second quarter, HoldingsChannel.com reports. The fund owned 2,391 shares of the medical research company's stock after buying an additional 420 shares during the quarter.
from Biotech News
0 Comments